Literature DB >> 17922890

Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.

K Imamura1, K Wada-Isoe, M Kitayama, K Nakashima.   

Abstract

OBJECTIVE: We investigated executive function in Parkinson's disease (PD) patients, and focused on executive dysfunction in PD with hallucinations, but without dementia.
METHODS: PD patients were classified by cognitive or neuropsychotic status as PD group, PD with vivid dreaming group, PD with hallucinations group and Parkinson's disease dementia (PDD) group. Psychomotor speed tests, the Stroop test, a verbal fluency test and the Self-rating Depression Scale were performed.
RESULTS: The PDD group showed poorer scores in every test compared with the PD group. The PD with hallucinations group showed results similar to those of the PDD group, while the PD with vivid dreaming group was similar to the PD group.
CONCLUSIONS: The study suggests that PD patients with hallucinations, not extensive enough to qualify as dementia, already have executive dysfunction similar to that seen in PDD patients. Executive dysfunction may be an important substrate for hallucinations even when dementia is not yet apparent.

Entities:  

Mesh:

Year:  2007        PMID: 17922890     DOI: 10.1111/j.1600-0404.2007.00933.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  P300 and the stroop effect in overweight minority adolescents.

Authors:  Lance O Bauer; Richard F Kaplan; Victor M Hesselbrock
Journal:  Neuropsychobiology       Date:  2010-03-18       Impact factor: 2.328

2.  Advances in the treatment of visual hallucinations in neurodegenerative diseases.

Authors:  Daniel Collerton; John-Paul Taylor
Journal:  Future Neurol       Date:  2013-07

3.  Multi-modal hallucinations and cognitive function in Parkinson's disease.

Authors:  Heather Katzen; Connie Myerson; Spiridon Papapetropoulos; Fatta Nahab; Bruno Gallo; Bonnie Levin
Journal:  Dement Geriatr Cogn Disord       Date:  2010-07-31       Impact factor: 2.959

Review 4.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

5.  Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease.

Authors:  Eun Jin Yoon; Zahinoor Ismail; Alexandru Hanganu; Mekale Kibreab; Tracy Hammer; Jenelle Cheetham; Iris Kathol; Justyna R Sarna; Davide Martino; Sarah Furtado; Oury Monchi
Journal:  Neurology       Date:  2019-07-18       Impact factor: 11.800

6.  Visual hallucinations in Lewy body disease: pathophysiological insights from phenomenology.

Authors:  Fabrizia D'Antonio; Maddalena Boccia; Antonella Di Vita; Antonio Suppa; Andrea Fabbrini; Marco Canevelli; Francesca Caramia; Marco Fiorelli; Cecilia Guariglia; Stefano Ferracuti; Carlo de Lena; Dag Aarsland; Dominic Ffytche
Journal:  J Neurol       Date:  2022-01-31       Impact factor: 6.682

Review 7.  Cerebral correlates of psychotic syndromes in neurodegenerative diseases.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

8.  Compensatory shifts in visual perception are associated with hallucinations in Lewy body disorders.

Authors:  Alan Robert Bowman; Vicki Bruce; Christopher J Colbourn; Daniel Collerton
Journal:  Cogn Res Princ Implic       Date:  2017-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.